Research programme: antibacterials - BioNTech
Alternative Names: Precision antibacterialsLatest Information Update: 12 Jul 2022
At a glance
- Originator BioNTech
- Class Antibacterials; Bacteriophages; Endolysins; Recombinant proteins
- Mechanism of Action Cell death stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Bacterial infections